Skip to content
Link copied to clipboard
Link copied to clipboard

Temple research finds that tweaking CBD may help it curb pain and opioid use in mice

Doylestown-based Neuropathix is running safety tests required to start clinical trials in humans. The compound may help with neuropathy, a severe type of chronic pain associated with cancer treatment.

Sara Jane Ward holds two vials of CBD in her hands in her lab at Temple University in 2018. She is now studying a modified version of CBD to treat chemotherapy-induced pain.
Sara Jane Ward holds two vials of CBD in her hands in her lab at Temple University in 2018. She is now studying a modified version of CBD to treat chemotherapy-induced pain.Read moreDAVID SWANSON / Staff Photographer